Jane Street Group, LLC Novo Nordisk A S Put Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $51 Million - $62.3 Million	428,500 New	428,500 $51 Million
Q1 2022 May 17, 2022	BUY	$93.1 - $112.54 $1.2 Million - $1.45 Million	12,900 Added 27.56%	59,700 $6.63 Million
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $1.48 Million - $1.8 Million	15,400 Added 49.04%	46,800 $5.24 Million
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $1.27 Million - $1.6 Million	15,000 Added 91.46%	31,400 $3.02 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $426,258 - $533,988	6,300 Added 62.38%	16,400 $1.37 Million
Q1 2021 May 18, 2021	SELL	$67.06 - $75.82 $637,070 - $720,289	-9,500 Reduced 48.47%	10,100 $681,000
Q4 2020 Feb 17, 2021	BUY	$63.89 - $73.8 $530,287 - $612,540	8,300 Added 73.45%	19,600 $1.37 Million
Q3 2020 Nov 17, 2020	SELL	$63.69 - $70.22 $566,841 - $624,958	-8,900 Reduced 44.06%	11,300 $785,000
Q2 2020 Aug 17, 2020	BUY	$58.54 - $67.94 $304,408 - $353,288	5,200 Added 34.67%	20,200 $1.32 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $341,274 - $446,982	6,900 Added 85.19%	15,000 $903,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $104,706 - $122,346	-2,100 Reduced 20.59%	8,100 $469,000
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $1.04 Million - $1.17 Million	-21,900 Reduced 68.22%	10,200 $527,000
Q2 2018 Aug 15, 2018	BUY	$44.29 - $50.42 $101,867 - $115,966	2,300 Added 7.72%	32,100 $1.48 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $1.45 Million - $1.73 Million	29,800 New	29,800 $1.47 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.